We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
OctoPlus Wins Drug Development and Manufacturing Contract from Danish Pharmaceutical Company
News

OctoPlus Wins Drug Development and Manufacturing Contract from Danish Pharmaceutical Company

OctoPlus Wins Drug Development and Manufacturing Contract from Danish Pharmaceutical Company
News

OctoPlus Wins Drug Development and Manufacturing Contract from Danish Pharmaceutical Company

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "OctoPlus Wins Drug Development and Manufacturing Contract from Danish Pharmaceutical Company"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

OctoPlus N.V. has announced that a process development and manufacturing contract has been signed with a pharmaceutical company headquartered in Denmark.

The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.

Under the contract terms, we will perform process development and manufacturing of a microsphere-based formulation for our client.

At OctoPlus we provide formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide.

In addition to our expertise in formulation and manufacturing, we offer our clients drug delivery technologies for the development of controlled release versions of existing or new drugs.

Advertisement